| Schedule of Shares and Share Equivalents Outstanding |
Further, immediately prior to the Merger,
the shares and share equivalents outstanding are summarized as follows:
| | |
Common
Stock | | |
Preferred
Stock
(all classes) | | |
Stock
Options | | |
Warrants | |
| Shares outstanding - post split | |
| 386 | | |
| 3,075 | | |
| 279 | | |
| - | |
| Shares issued upon note conversion (a) | |
| 534,850 | | |
| | | |
| | | |
| | |
common shares issued to advisors (c) | |
| 376,256 | | |
| | | |
| | | |
| | |
| penny warrants issued (b) | |
| | | |
| | | |
| | | |
| 6,008,589 | |
| Stock options issued under 2025 plan | |
| | | |
| | | |
| 2,762,901 | | |
| | |
| | |
| 911,492 | | |
| 3,075 | | |
| 2,763,180 | | |
| 6,008,589 | |
| a. | All convertible notes plus accrued interest outstanding at
the Merger date were converted into 534,850 shares of common stock |
| b. | Warrants to purchase 6,008,589 shares of common stock at
$0.01 per share were issued to investors. The Company received $6,008 from the exercise of such warrants at the Merger date. |
| c. | Issued 376,256 common shares to consultants, advisors and
for terminating a share subscription agreement. |
| a. | The first put/call option agreement between the Company,
ReShape Lifesciences, Inc, renamed as Vyome Holdings, Inc. (“VHI’). Through this agreement, 1,322,081 shares of common stock
held by Indian stockholders of the Company are entitled to be exchanged for 825,448 shares of VHI common stock pursuant to the put/call
exercise in the future as per the terms of the agreements. |
| b. | The second put/call option agreement is between the Company’s
Indian subsidiary, VHI, and investors in the bridge investments that came in the form of Compulsory Convertible Debentures that were
converted to 86 shares in the Indian subsidiary at the Merger closing. Those shares are entitled to be exchanged for 800,361 shares of
common stock of VHI pursuant to the put/call exercise in the future as per the terms of the agreements. |
| c. | The third put/call option agreement is between the Company’s
Indian subsidiary, VHI, and investors for the concurrent (concurrent to Merger closing) financing for subscription of 999 shares in the
Indian subsidiary. Those shares are entitled to be exchanged for 89,671 shares of common stock of VHI pursuant to the put/call exercise
in the future as per terms of this agreements. |
|